Stock Ticker

  • Loading stock data...

Bellicum Pharmaceuticals, Inc. and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Announce Reconstruction of License Agreement

Boston, MA 10/06/2014 (wallstreetpr) – According to reports, Bellicum Pharmaceuticals, Inc and Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) have decided to announce the reconstruction of their license agreement for cell-signaling technology of ARIA. Insights of the matter: As part of the reconstruction process, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) will get $50 million in exchange for a fully paid […]

Four Stocks To Watch: Twenty-First Century Fox Inc (FOXA), QUALCOMM Inc. (QCOM), DryShips Inc. (DRYS), Ariad Pharmaceuticals Inc. (ARIA)

Boston, MA 10/04/2014 (wallstreetpr) – Leonardo DiCaprio, who is currently acting in Twenty-First Century Fox Inc (NASDAQ:FOXA)‘s most awaited movie ‘ The Revenant,’ has decided to take a break from acting career for some time. He was slated to work in Walter Isaacson’s biography of Steve Jobs. It is currently learnt that DiCaprio has said […]

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner Acquires Shares Indirectly

Boston, MA 08/21/2114 (wallstreetpr) – A global oncology company, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) Director Alexander Denner had resorted to buying the company shares from the open market indirectly on August 15. The acquisition of shares was done for Sarissa Capital for two of its funds. Interestingly, the move comes in the wake of a Sell […]

Wall Street Takeaway: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), TherapeuticsMD Inc (NYSEMKT:TXMD), GoPro Inc (NASDAQ:GPRO)

Boston, MA 07/09/2014 (wallstreetpr) – The uncertainty in the biotech sector went down with Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) in the last session, putting it among the most active losers of the day. The stock slumped nearly 4 percent to $6.06 per share. The stock is down more than 11 percent this year. The U.S. biotech […]

In New Data, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) May Seek Expanded Treatment Scope For Iclusig

Boston, MA 06/02/2014 (wallstreetpr) – The cancer drug company Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has had its fair share of disappointments with its approved leukemia drug, Iclusig. From market suspension to halting of the study of the drug in newly-diagnosed patients, Ariad has seen it all but the company looks unbowed. At the weekend, Ariad released […]

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): Long Way To Go

Boston, MA 05/28/2014 (wallstreetpr) – Total revenue for the first quarter was $11.8 million, which includes $8 million as product revenue and $3.8 million as license revenue. Initiate growth Net product revenues including sales of Iclusig were $8.0 million, 25% year over year increase compared to $6.4 million during the same period last year. It includes […]

Monday Stock Roundup: Nokia Corporation (ADR) (NYSE:NOK), Pfizer Inc.(NYSE:PFE), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Boston, MA 03/03/2014 (wallstreetpr) – Nokia Corporation (ADR) (NYSE:NOK): The Supreme court in India starts hearing of the appeal dislodged by Nokia in efforts to overturn the running by a lower court in Delhi. The company is fighting tax crime allegations and its believes that the Delhi High Court issued “new conditions” for the transfer of […]

What Investors Should Known About Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), American Realty Capital Properties Inc (NASDAQ:ARCP), Sunedison Inc (NYSE:SUNE)

Boston, MA 02/28/2014 (wallstreetpr) – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was last seen up more than 5 percent to $8.99. A volume of more than 23 million shares were traded in the last session, making the stock one the notable movers on Nasdaq. The stock escalated to $9.05 in the day and touched a low of […]

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): Expectations and Realities

Boston, MA 02/27/2014 (wallstreetpr) –  Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), after posting better than expected results at a time when it has come to known as controversial and volatile, is now attracting news analysts’ sentiments. Yet the company is also blowing its own trumpet and placing a lot of hopes in its recently re-launched leukemia drug […]

On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO)

Boston, MA 02/25/2014 (wallstreetpr) – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) releases its fiscal 2013 fourth quarter early morning Tuesday, February 25. The company is expected to report earnings of (47 cents) per share. Revenue is expected to come in at $6.31 million. These are estimates issued by analysts tracking the stock. ARIA has a consensus “hold” […]

Stocks on the Spotlight: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Oi SA (ADR) (NYSE:OIBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Boston, MA 02/20/2014 (wallstreetpr) – Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) could soon be without the services of its billionaire chairman Philip Frost if reports appearing on the media are true. It is reported that the entrepreneur might leave the Israel-based TEVA before his current terms expires next year. However, some other reports say that Mr. […]

Investor Digest: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Morgan Stanley (NYSE:MS), Yamana Gold Inc. (USA) (NYSE:AUY)

Boston, MA 02/20/2014 (wallstreetpr) – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): According to the latest 13F filings, Sarissa Capital managed by Alex Denner revealed holding about 12 million shares of ARIA common stock. Given that amount of common stock ownership, the hedge fund’s stake in the biotech company is roughly 6.2 percent. Mr. Denner has expansive understanding of […]

Shareholder Breakfast: JPMorgan Chase & Co. (NYSE:JPM), Gilead Sciences, Inc. (NASDAQ:GILD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

Boston, MA 02/19/2014 (wallstreetpr) – JPMorgan Chase & Co. (NYSE:JPM) is mourning the death of yet another one of its bankers. The leading U.S. lender and global banking services provider started the week with the tragic death of one of its investment banker who plunged to death from the roof of its 30-storey headquarters in […]

Vodafone Group Plc (ADR) (NASDAQ:VOD) BlackBerry Ltd (NASDAQ:BBRY) And Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) The Battle Ahead

Boston, MA 02/17/2014 (wallstreetpr) – Vodafone Group Plc (ADR) (NASDAQ:VOD) is fighting its out in the Indian sub-continent. It is expected to spend almost $3 billion to acquire spectrum. Its nearest rival is also spending the same amount as the Indian government auctions spectrum for 3G and 4G services. Vodafone has already signaled that it […]

Advanced Micro Devices, Inc. (NYSE:AMD), Alpha Natural Resources, Inc. (NYSE:ANR) and ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) Mark Time

Boston, MA 02/13/2014 (wallstreetpr) – US-origin Advanced Micro Devices, Inc. (NYSE:AMD) which has cornered the niche advanced electronic device market with its bleeding-edge technology platforms, appears to be turning the corner on the next technology level. In close competition with long-time same niche player INTEL, AMD has its work cut out. Transforming technology, which both […]